Evidence map›Paper›PMID 35879413›Full record

SynthesisNature genetics2022

Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.

Antoine Rebendenne, Priyanka Roy, Boris Bonaventure, Ana Luiza Chaves Valadão, Lowiese Desmarets, Mary Arnaud-Arnould, Yves Rouillé, Marine Tauziet, Donatella Giovannini, Jawida Touhami and 13 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 2 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 2 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Mucins and Respiratory Virus Infection.Annual review of virology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 3 countries.

Antoine RebendenneIRIM, CNRS, Montpellier University, Montpellier, France.ORCID http://orcid.org/0000-0001-8913-837X
Priyanka RoyGenetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-2934-538X
Boris Bonaventure *IRIM, CNRS, Montpellier University, Montpellier, France.
Ana Luiza Chaves Valadão *IRIM, CNRS, Montpellier University, Montpellier, France.
Lowiese DesmaretsLille University, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Lille, France.ORCID http://orcid.org/0000-0001-5077-3333
Mary Arnaud-ArnouldIRIM, CNRS, Montpellier University, Montpellier, France.ORCID http://orcid.org/0000-0003-2799-1011
Yves RouilléLille University, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Lille, France.
Marine TauzietIRIM, CNRS, Montpellier University, Montpellier, France.
Donatella GiovanniniIGMM, CNRS, Montpellier University, Montpellier, France.
Jawida TouhamiIGMM, CNRS, Montpellier University, Montpellier, France.
Yenarae LeeGenetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Peter DeWeirdtGenetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Mudra HegdeGenetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-4530-4633
Serge UrbachIGF, Montpellier University, CNRS, INSERM, Montpellier, France.
Khadija El KoulaliBCM, Montpellier University, CNRS, INSERM, Montpellier, France.
Francisco Garcia de GraciaIRIM, CNRS, Montpellier University, Montpellier, France.
Joe McKellarIRIM, CNRS, Montpellier University, Montpellier, France.
Jean DubuissonLille University, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Lille, France.
Mélanie WenckerCIRI, INSERM, CNRS, ENS-Lyon, Lyon University, Lyon, France.
Sandrine BelouzardLille University, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Lille, France.
Olivier MoncorgéIRIM, CNRS, Montpellier University, Montpellier, France.ORCID http://orcid.org/0000-0003-0512-1824
John G DoenchGenetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA. jdoench@broadinstitute.org.ORCID http://orcid.org/0000-0002-3707-9889
Caroline GoujonIRIM, CNRS, Montpellier University, Montpellier, France. caroline.goujon@irim.cnrs.fr.ORCID http://orcid.org/0000-0001-8571-1108
Centre National de la Recherche Scientifique · FRBroad Institute · USUniversité Claude Bernard Lyon 1 · FR

Funding

CRISPR screens for SARS-CoV-2 Host FactorsR21AI157835 · NIAID · BROAD INSTITUTE, INC. · PI DOENCH, JOHN GERARD · 2020 to 2020
$440k
European Research Council 759226NIAID NIH HHS R21 AI157835
6 · The paper itself

Abstract

CRISPR knockout (KO) screens have identified host factors regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication. Here, we conducted a meta-analysis of these screens, which showed a high level of cell-type specificity of the identified hits, highlighting the necessity of additional models to uncover the full landscape of host factors. Thus, we performed genome-wide KO and activation screens in Calu-3 lung cells and KO screens in Caco-2 colorectal cells, followed by secondary screens in four human cell lines. This revealed host-dependency factors, including AP1G1 adaptin and ATP8B1 flippase, as well as inhibitors, including mucins. Interestingly, some of the identified genes also modulate Middle East respiratory syndrome coronavirus (MERS-CoV) and seasonal human coronavirus (HCoV) (HCoV-NL63 and HCoV-229E) replication. Moreover, most genes had an impact on viral entry, with AP1G1 likely regulating TMPRSS2 activity at the plasma membrane. These results demonstrate the value of multiple cell models and perturbational modalities for understanding SARS-CoV-2 replication and provide a list of potential targets for therapeutic interventions.

Indexed as

COVID-19Middle East Respiratory Syndrome CoronavirusCaco-2 CellsClustered Regularly Interspaced Short Palindromic RepeatsHumansSARS-CoV-2Seasons

Identifiers

PMID35879413
PMCPMC11627114
OpenAlexW4287510130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.